SAB Biotherapeutics Stock (SABS)
Track SAB Biotherapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
SABS
SAB Biotherapeutics
healthcare
$3.60
▲ +1.82 (+102.25%) past year
Market Cap
$291.33M
P/E Ratio
—
1Y Return
+102.25%
EPS (TTM)
-$2.47
Read the latest TheStreet Pro articles mentioning SAB Biotherapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning SABS yet.
Daily Diary Mentions
0 mentionsNo diary mentions for SABS yet.